Real-World Evidence on Treatment Retention, Safety, and Tolerability of Edaravone in Canadian Patients With Amyotrophic Lateral Sclerosis

被引：0
|
作者：
Pham, Dung [1 ]
St-Onge, Louise [1 ]
Ng, Ryan [2 ]
Neish, Calum S. [2 ]
Yap, Belinda [3 ]
Apple, Stephen [4 ]
机构：
[1] Mitsubishi Tanabe Pharma Canada Inc, Toronto, ON, Canada
[2] IQVIA Solut Canada Inc, Toronto, ON, Canada
[3] Innomar Strategies, Oakville, ON, Canada
[4] Mitsubishi Tanabe Pharma Amer, Jersey City, NJ USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
89
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] Long-term effects of edaravone on patients with amyotrophic lateral sclerosis
    Okada, M.
    Ueyamaa, H.
    Ishizaki, M.
    Maeda, Y.
    Yamashita, S.
    Ando, Y.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 572 - 572
  • [42] Safety of butylphthalide and edaravone in patients with ischemic stroke: a multicenter real-world study
    ShuXian LYU
    DongFang QIAN
    YuFei FENG
    ChengWu SHEN
    LuBo GUO
    JianTao LYU
    PengFei JIN
    Ting LI
    SiYuan TAN
    ZiXuan ZHANG
    Lin HUANG
    Xue ZHONG
    LeQun SU
    Xin HU
    Xin HUANG
    XueYan CUI
    Journal of Geriatric Cardiology, 2023, 20 (04) : 293 - 308
  • [43] Real-World Evidence on Treatment Initiation and Discontinuation in Canadian Osteoporotic Patients.
    Meilleur, Marie-Claude
    Cloutier, Martin
    Royer, Jimmy
    Krishna, Arun
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S197 - S197
  • [44] Safety of butylphthalide and edaravone in patients with ischemic stroke: a multicenter real-world study
    Shu-Xian LYU
    Dong-Fang QIAN
    Yu-Fei FENG
    Cheng-Wu SHEN
    Lu-Bo GUO
    Jian-Tao LYU
    Peng-Fei JIN
    Ting LI
    Si-Yuan TAN
    Zi-Xuan ZHANG
    Lin HUANG
    Xue ZHONG
    Le-Qun SU
    Xin HU
    Xin HUANG
    Xue-Yan CUI
    Journal of Geriatric Cardiology, 2023, 20 (04) : 293 - 308
  • [45] Pilot Study of Real-World Monitoring of the Heart Rate Variability in Amyotrophic Lateral Sclerosis
    Brown, Alexander A.
    Ferguson, Bradley J.
    Jones, Vovanti
    Green, Bruce E.
    Pearre, Justin D.
    Anunoby, Ifeoma A.
    Beversdorf, David Q.
    Barohn, Richard J.
    Cirstea, Carmen M.
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2022, 5
  • [46] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Ofir Zmira
    Alex I. Halpern
    Lital Abraham
    Anat Achiron
    Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
  • [47] Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
    Verkkoniemi-Ahola, Auli
    Hartikainen, Paivi
    Hassi, Katja
    Kuusisto, Hanna
    Lahdenpera, Sanni
    Mehtala, Juha
    Viitala, Matias
    Ylisaukko-oja, Tero
    Soilu-Hanninen, Merja
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (04)
  • [48] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [49] Real-World Experience and Strategies to Enhance the Palatability of the Combination Sodium Phenylbutyrate and Taurursodiol for the Treatment of Amyotrophic Lateral Sclerosis
    Timmons, Jamie
    Fox, Kelly
    Oliff, Layne
    Petersen, Gwen
    Manuel, Machelle
    MUSCLE & NERVE, 2023, 68 : S43 - S44
  • [50] Real-World Efficacy, Tolerability and Safety of Ubrogepant
    Chiang, C. C.
    Arca, K.
    Dunn, R.
    Girardo, M.
    Quillen, J.
    Dodick, D. W.
    Starling, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 96 - 96
12345